Pseudowintera colorata (Raoul) Dandy Hydro-Alcohol Leaf Extract Inhibits Bacterial Triggers of Some Autoimmune Inflammatory Diseases

groupview

Abstract
Pharmacognosy Communications,2017,7,4,164-171.
Published:November 2017
Type:Original Article

Pseudowintera colorata (Raoul) Dandy Hydro-Alcohol Leaf Extract Inhibits Bacterial Triggers of Some Autoimmune Inflammatory Diseases

Celia Barillot1,2, Craig Davis3,4 Ian Edwin Cock1,5*

1Environmental Futures Research Institute, Griffith University, Brisbane, AUSTRALIA.

2School of Biology, Ecole de Biologie Industrielle (EBI), Cergy, FRANCE.

3Botanical Medicine Research Institute, Brisbane, AUSTRALIA.

4Bioextracts P/L, Brisbane, AUSTRALIA.

5School of Natural Sciences, Griffith University, Brisbane, AUSTRALIA.

Abstract:

Introduction: Pseudowintera colorata (Raoul) Dandy is an evergreen shrub which is endemic to New Zealand. Decoctions, infusions and essential oils produced from the leaves were used traditionally to treat a variety of bacterial diseases. Despite this, P. colorata leaf extracts have not been rigorously examined for inhibitory activity against bacterial triggers of autoimmune inflammatory diseases. Methods: A P. colorata hydro-alcohol leaf extract was analysed for antioxidant capacity by the DPPH free radical scavenging assay. Growth inhibitory activities against bacterial species associated with initiating rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis and rheumatic fever were determined by disc diffusion assay and quantified by MIC determination. Toxicity was determined by Artemia franciscana bioassay. Results: The P. colorata hydro-alcohol leaf extract displayed good DPPH radical scavenging activity, with an antioxidant capacity of 52 μg/ mL ascorbic acid equivalency. The extract inhibited the growth of all of the bacterial triggers of autoimmune inflammatory diseases tested. It was a particularly potent inhibitor of A. baylyi, with MIC values as low as 427 μg/ mL against the clinical strain. P. mirabilis and P. vulgaris were also highly susceptible to the P. colorata hydro-alcohol leaf extract, with MIC values of approximately 800-900 μg/mL against all strains. The extract was also a moderate growth inhibitor (MIC >1000 μg/mL) of all other bacterial strains tested. The extract was determined to be nontoxic in the Artemia franciscana nauplii bioassay with 24 h LC50 values substantially >1000 μg/mL, indicating its safety for therapeutic use. Conclusion: The lack of toxicity of the P. colorata leaf extracts and their growth inhibitory bioactivity against a panel of bacterial triggers of autoimmune inflammatory diseases indicate their potential in the prevention and treatment of these diseases in genetically susceptible individuals.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.